Figure 2B depicted multiple PELI1 mutation sites in the TCGA cohort, with R145Q/W representing the most frequently altered locus. Two samples from TCGA database harbored this mutation—one from UCEC and another from skin cutaneous melanoma (SKCM). However, the R145Q/W alteration of PELI1 did not significantly affect clinical survival in these UCEC and SKCM cases (Figure 2C). This evidence concerns the gene PELI1 and cutaneous melanoma.